Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BIO Wants Tighter Controls For Plant-Made Drugs, But No Fencing

Executive Summary

More details should be required for a permit to grow biotechnology-derived crops, the Biotechnology Industry Organization says in comments on a joint FDA/Department of Agriculture draft guidance on plant-made pharmaceuticals

You may also be interested in...

ProdiGene To Develop “Field Trial” Compliance Program Following Violation

ProdiGene is working with FDA and USDA to develop a compliance program as part of a settlement agreement relating to safety violations in the production of plant-made pharmaceuticals

Good “Pharming” Practices: FDA Outlines CMCs For Plant-Made Drugs

Pharmaceuticals derived from bioengineered plants should include a description of harvesting methods in the chemistry, manufacturing & controls section of NDAs and BLAs, a joint FDA/USDA 1draft guidance on plant-made pharmaceuticals says

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts